Company intelligence / Profile preview
Laboratorios Mallén
- Ownership
- Private
- Development stage
- Commercial
Overview
Laboratorios Mallén manufactures and markets over fifty branded pharmaceutical products across several therapeutic areas. The company has expanded regionally since at least 2017 and operates a modern manufacturing facility compliant with good manufacturing practices. Recent launches include treatments for urinary tract infections and reproductive health solutions. No specific clinical trial results are published; the company appears focused on commercialized generics or branded generics rather than novel drug development.
- Therapeutic areas
- Infectious DiseasesPulmonologyOtherRheumatologyGastroenterologyCardiovascularWomen's Health
- Modalities
- Small molecules (e.g., fosfomicina, hydroxyzine HCl)General pharmaceutical preparations
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Laboratorios Mallén.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratorios Mallén.